Screener
Jade Biosciences JBIO Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $55,085 | $88,438 |
| Investments | 256,210 | 247,720 |
| Prepaid expenses and other current assets | 7,222 | 12,658 |
| Total current assets | 318,517 | 348,816 |
| Property and equipment, net | 157 | 170 |
| Operating lease right-of-use asset | 690 | 726 |
| Other assets | 69 | 69 |
| Total assets | $319,433 | $349,781 |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's total current assets?
- Jade Biosciences (JBIO) reported total current assets of $318.52M in Q1 2026.
- How has Jade Biosciences's total current assets changed year-over-year?
- Jade Biosciences's total current assets increased by 311.7% year-over-year, from $77.37M to $318.52M.
- What is the long-term trend for Jade Biosciences's total current assets?
- Over 5 years (2020 to 2025), Jade Biosciences's total current assets has grown at a 136.9% compound annual growth rate (CAGR), from $4.68M to $348.82M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Jade Biosciences's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude